Contributor: Fuel drug development, not Big Pharma’s profits
RSS SUMMARY · AGGREGATED FROM LAT
More than 200 drugs in the pipeline for ALS are stuck in a system that favors big, slow-moving pharmaceutical companies.
More than 200 drugs in the pipeline for ALS are stuck in a system that favors big, slow-moving pharmaceutical companies.
More than 200 drugs in the pipeline for ALS are stuck in a system that favors big, slow-moving pharmaceutical companies.
Continue Reading
The full story continues on Los Angeles Times.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
LAT
Sports
How ‘Welcome to Wrexham’ kickstarted a $250-million economic boom for Welsh town
LAT·2h ago·3 min read
Sports
Prep talk: Villa Park pitching duo will be tough to stop in Division 2 baseball playoffs
LAT·2h ago·3 min read
Entertainment
Diego Calva was asked to ‘erase’ his Mexican accent. He chose to embrace it instead
LAT·3h ago·3 min read
Lifestyle
Massive and made of fiberglass, Muffler Men are a Route 66 classic — and they’re multiplying
LAT·3h ago·3 min read
Related
On this beat
Science
Scientists reversed biological age in older adults with a 4-week diet change
SD·49m ago·3 min read
Science
A hidden wildfire pollutant causes thousands of excess deaths per year, satellite data shows
SPACE·1h ago·3 min read
Science
This strange giant dinosaur may change what we know about Jurassic titans
SD·3h ago·3 min read
Science
Scientists say this algae could remove microplastics from drinking water
SD·2h ago·3 min read